Outcome of uterine sarcoma patients treated with pazopanib: A retrospective analysis based on two European Organisation for Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group (STBSG) clinical trials 62043 and 62072

C. Benson; I. Ray-Coquard; S. Sleijfer; S. Litière; J.-Y. Blay; A. Le Cesne; Z. Papai; I. Judson; P. Schöffski; S. Chawla; T. Gil; S. Piperno-Neumann; S. Marréaud; M.R. Dewji; W.T.A. van der Graaf

doi:10.1016/j.ygyno.2016.03.024

Outcome of uterine sarcoma patients treated with pazopanib: A retrospective analysis based on two European Organisation for Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group (STBSG) clinical trials 62043 and 62072

Gynecologic Oncology ◽

10.1016/j.ygyno.2016.03.024 ◽

2016 ◽

Vol 142 (1) ◽

pp. 89-94 ◽

Cited By ~ 22

Author(s):

C. Benson ◽

I. Ray-Coquard ◽

S. Sleijfer ◽

S. Litière ◽

J.-Y. Blay ◽

...

Keyword(s):

Clinical Trials ◽

Soft Tissue ◽

Retrospective Analysis ◽

Bone Sarcoma ◽

Uterine Sarcoma ◽

European Organisation

Download Full-text

Impact of chemotherapy in uterine sarcoma (UtS): review of 13 clinical trials from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) involving advanced/metastatic UtS compared to other soft tissue sarcoma (STS) patients treated with first line chemotherapy

Gynecologic Oncology ◽

10.1016/j.ygyno.2016.05.016 ◽

2016 ◽

Vol 142 (1) ◽

pp. 95-101 ◽

Cited By ~ 7

Author(s):

I. Ray-Coquard ◽

E. Rizzo ◽

J.Y. Blay ◽

P. Casali ◽

I. Judson ◽

...

Keyword(s):

Clinical Trials ◽

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Bone Sarcoma ◽

Uterine Sarcoma ◽

First Line ◽

Line Chemotherapy

Download Full-text

Association of pazopanib-induced toxicities with outcome of patients with advanced soft tissue sarcoma; a retrospective analysis based on the European Organisation for Research and Treatment of Cancer (EORTC) 62043 and 62072 clinical trials

Acta Oncologica ◽

10.1080/0284186x.2019.1581376 ◽

2019 ◽

Vol 58 (6) ◽

pp. 872-879 ◽

Cited By ~ 6

Author(s):

Melissa Vos ◽

Stefan Sleijfer ◽

Saskia Litière ◽

Nathan Touati ◽

Florence Duffaud ◽

...

Keyword(s):

Clinical Trials ◽

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Retrospective Analysis ◽

Advanced Soft Tissue Sarcoma ◽

European Organisation

Download Full-text

Outcome of chemotherapy in advanced synovial sarcoma patients: Review of 15 clinical trials from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group; setting a new landmark for studies in this entity

European Journal of Cancer ◽

10.1016/j.ejca.2016.02.002 ◽

2016 ◽

Vol 58 ◽

pp. 62-72 ◽

Cited By ~ 63

Author(s):

Myrella Vlenterie ◽

Saskia Litière ◽

Elisa Rizzo ◽

Sandrine Marréaud ◽

Ian Judson ◽

...

Keyword(s):

Clinical Trials ◽

Soft Tissue ◽

Synovial Sarcoma ◽

Bone Sarcoma ◽

Group Setting ◽

European Organisation

Download Full-text

Pazopanib in uterine sarcoma (UtS): Review of two European Organisation for Research and Treatment of Cancer (EORTC) and GSK clinical trials 62043 and 62072 on pazopanib for soft tissue sarcoma (STS).

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.10579 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 10579-10579 ◽

Cited By ~ 2

Author(s):

Isabelle Laure Ray-Coquard ◽

Stefan Sleijfer ◽

Saskia Litière ◽

Jean-Yves Blay ◽

Axel Le Cesne ◽

...

Keyword(s):

Clinical Trials ◽

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Uterine Sarcoma ◽

European Organisation

Download Full-text

Review of the clinical trials activity of the soft tissue and bone sarcoma group of the european organization for research and treatment of cancer

Seminars in Surgical Oncology ◽

10.1002/ssu.2980040110 ◽

1988 ◽

Vol 4 (1) ◽

pp. 45-52 ◽

Cited By ~ 3

Author(s):

Vivien H. C. Bramwell ◽

A. Santoro ◽

J. Rouesse ◽

H. Mouridsen ◽

W. Steward ◽

...

Keyword(s):

Clinical Trials ◽

Soft Tissue ◽

Bone Sarcoma ◽

European Organization

Download Full-text

Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: An European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group randomised phase II and pharmacogenetic study

European Journal of Cancer ◽

10.1016/j.ejca.2013.10.002 ◽

2014 ◽

Vol 50 (2) ◽

pp. 388-396 ◽

Cited By ~ 19

Author(s):

H. Gelderblom ◽

J.Y. Blay ◽

B.M. Seddon ◽

M. Leahy ◽

I. Ray-Coquard ◽

...

Keyword(s):

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Phase Ii ◽

Bone Sarcoma ◽

First Line ◽

Pharmacogenetic Study ◽

European Organisation ◽

Metastatic Soft Tissue Sarcoma ◽

Line Chemotherapy

Download Full-text

Activity of eribulin mesylate (E7389) in patients with soft tissue sarcoma (STS): Phase II studies of the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group (EORTC 62052).

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.10031 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 10031-10031 ◽

Cited By ~ 7

Author(s):

P. Schoffski ◽

I. L. Ray-Coquard ◽

A. Cioffi ◽

N. Bin Bui ◽

S. Bauer ◽

...

Keyword(s):

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Phase Ii ◽

Bone Sarcoma ◽

Eribulin Mesylate ◽

European Organisation ◽

Phase Ii Studies

Download Full-text

3439 Prognostic factors in soft tissue sarcoma patients with lung metastases only receiving first-line chemotherapy. An exploratory, retrospective analysis on fifteen trials of the European Organization for Research and Treatment of Cancer - Soft Tissue and Bone Sarcoma Group (EORTC-STBSG)

European Journal of Cancer ◽

10.1016/s0959-8049(16)31912-8 ◽

2015 ◽

Vol 51 ◽

pp. S701

Author(s):

L. Lindner ◽

S. Litiere ◽

S. Sleijfer ◽

I. Judson ◽

A. Italiano ◽

...

Keyword(s):

Prognostic Factors ◽

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Retrospective Analysis ◽

Lung Metastases ◽

Bone Sarcoma ◽

First Line ◽

European Organization ◽

Line Chemotherapy

Download Full-text

Faculty Opinions recommendation of Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: a phase II study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC study 62043).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1160744.622149 ◽

2009 ◽

Author(s):

Florence Duffaud

Keyword(s):

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Phase Ii ◽

Phase Ii Study ◽

Angiogenesis Inhibitor ◽

Bone Sarcoma ◽

Advanced Soft Tissue Sarcoma ◽

European Organisation

Download Full-text

Faculty Opinions recommendation of Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas: an exploratory, retrospective analysis on large series from the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1355961.827061 ◽

2009 ◽

Author(s):

Florence Duffaud

Keyword(s):

Soft Tissue ◽

Retrospective Analysis ◽

Predictive Factors ◽

Soft Tissue Sarcomas ◽

Bone Sarcoma ◽

Large Series ◽

Adult Patients ◽

First Line ◽

European Organization ◽

Prognostic And Predictive Factors

Download Full-text